CytoReason vs Predicta Med
CytoReason vs Predicta Med, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CytoReason is on 68/100 and Predicta Med on 32/100.
Where each one leads
CytoReason
- our overall score: 68/100 against 32/100
- domain rating: 40/100 against 30/100
- headcount: 116 against 21
- LinkedIn following: 12,830 against 2,174
Predicta Med
Leads on none of the measures we hold for both companies.
At a glance
| Measure | CytoReason | Predicta Med |
|---|---|---|
| What it is | Develops a computational model of the human body for drug discovery and development. | AI-powered platform for early detection and treatment selection of autoimmune diseases. |
| Category | Healthcare, Drug Discovery, Clinical Development, Biomarkers | Healthcare, Disease, Detection, Autoimmune |
| Sells toBusiness model | B2B | B2C |
| Offering | Software | Software |
| Founded | 2016 | 2019 |
| Headquarters | Tel Aviv, Israel | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | CytoReason | Predicta Med |
|---|---|---|
| Employees | 116 | 21 |
| Headcount growthLast 12 months | +13.7% | +13.1% |
| Total funding | $128M | Not published |
| Latest round | Series B | Strategic |
| LinkedIn followers | 12,830 | 2,174 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CytoReason | Predicta Med |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 68/100 | 32/100 |
| Traction | 60/100 | 13/100 |
| Team | 70/100 | 50/100 |
| Search visibility | 30/100 | 28/100 |
| Quality | 78/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 40/100 | 30/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CytoReason | Predicta Med |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Segment | Not detected |
CytoReason vs Predicta Med: common questions
Which is better, CytoReason or Predicta Med?
On our 0-100 score CytoReason rates higher (68/100 against 32/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do CytoReason and Predicta Med compare on the numbers?
CytoReason leads on our overall score (68/100 against 32/100), domain rating (40/100 against 30/100), headcount (116 against 21), LinkedIn following (12,830 against 2,174).
Read the full CytoReason review and pricing or the Predicta Med review and pricing. You can also browse other CytoReason alternatives we track.